Literature DB >> 34064143

The Emerging Concern and Interest SARS-CoV-2 Variants.

Edyta Janik1, Marcin Niemcewicz1, Marcin Podogrocki1, Ireneusz Majsterek2, Michal Bijak1.   

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) responsible for coronavirus disease 2019 (COVID-19) was discovered in December 2019 in Wuhan, China. Since that time, the virus has spread around the world, which resulted in an announcement of the World Health Organization (WHO), dated in March 2020, that COVID-19 was a worldwide pandemic, and since then, the world has been struggling with this disease. SARS-CoV-2, similar to other RNA viruses, continually mutates, and new variants are appearing. Among large numbers of detected SARS-CoV-2 variants, only an insignificant amount of them are able to pose a risk to public health, as they are more contagious and cause more severe conditions. The emerged variants were classified by the Centers for Disease Control and Prevention (CDC) in collaboration with SARS-CoV-2 Interagency Group (SIG) according to strictly defined pattern. Variants were classified as variants of concern, variants of interest, and variants of high consequence. In the last few months, three variants of concern (B.1.1.7, B.1.351, and P.1) and four variants of interests (B.1.526, B.1.525, B.1.427/B.1.429, and P.2) were distinguished and are essential for close monitoring. This analysis summarizes the principal information concerning SARS-CoV-2 variants, such as their infectivity, severity, mutations, and immune susceptibility.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; mutations; variants

Year:  2021        PMID: 34064143     DOI: 10.3390/pathogens10060633

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  48 in total

Review 1.  Rates of evolutionary change in viruses: patterns and determinants.

Authors:  Siobain Duffy; Laura A Shackelton; Edward C Holmes
Journal:  Nat Rev Genet       Date:  2008-03-04       Impact factor: 53.242

2.  Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma.

Authors:  Sandile Cele; Inbal Gazy; Laurelle Jackson; Shi-Hsia Hwa; Houriiyah Tegally; Gila Lustig; Jennifer Giandhari; Sureshnee Pillay; Eduan Wilkinson; Yeshnee Naidoo; Farina Karim; Yashica Ganga; Khadija Khan; Mallory Bernstein; Alejandro B Balazs; Bernadett I Gosnell; Willem Hanekom; Mahomed-Yunus S Moosa; Richard J Lessells; Tulio de Oliveira; Alex Sigal
Journal:  Nature       Date:  2021-03-29       Impact factor: 49.962

3.  SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities.

Authors:  Rochelle P Walensky; Henry T Walke; Anthony S Fauci
Journal:  JAMA       Date:  2021-03-16       Impact factor: 157.335

4.  Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.

Authors:  Sandipan Chakraborty
Journal:  Biochem Biophys Res Commun       Date:  2020-11-28       Impact factor: 3.575

5.  Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity.

Authors:  Erik Volz; Verity Hill; John T McCrone; Anna Price; David Jorgensen; Áine O'Toole; Joel Southgate; Robert Johnson; Ben Jackson; Fabricia F Nascimento; Sara M Rey; Samuel M Nicholls; Rachel M Colquhoun; Ana da Silva Filipe; James Shepherd; David J Pascall; Rajiv Shah; Natasha Jesudason; Kathy Li; Ruth Jarrett; Nicole Pacchiarini; Matthew Bull; Lily Geidelberg; Igor Siveroni; Ian Goodfellow; Nicholas J Loman; Oliver G Pybus; David L Robertson; Emma C Thomson; Andrew Rambaut; Thomas R Connor
Journal:  Cell       Date:  2020-11-19       Impact factor: 41.582

6.  SARS-CoV-2 variants combining spike mutations and the absence of ORF8 may be more transmissible and require close monitoring.

Authors:  Filipe Pereira
Journal:  Biochem Biophys Res Commun       Date:  2021-02-25       Impact factor: 3.575

7.  Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.

Authors:  Sam Abbott; Rosanna C Barnard; Christopher I Jarvis; Adam J Kucharski; James D Munday; Carl A B Pearson; Timothy W Russell; Damien C Tully; Alex D Washburne; Tom Wenseleers; Nicholas G Davies; Amy Gimma; William Waites; Kerry L M Wong; Kevin van Zandvoort; Justin D Silverman; Karla Diaz-Ordaz; Ruth Keogh; Rosalind M Eggo; Sebastian Funk; Mark Jit; Katherine E Atkins; W John Edmunds
Journal:  Science       Date:  2021-03-03       Impact factor: 63.714

8.  SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity.

Authors:  Lizhou Zhang; Cody B Jackson; Huihui Mou; Amrita Ojha; Haiyong Peng; Brian D Quinlan; Erumbi S Rangarajan; Andi Pan; Abigail Vanderheiden; Mehul S Suthar; Wenhui Li; Tina Izard; Christoph Rader; Michael Farzan; Hyeryun Choe
Journal:  Nat Commun       Date:  2020-11-26       Impact factor: 14.919

9.  Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.

Authors:  Bette Korber; Will M Fischer; Sandrasegaram Gnanakaran; Hyejin Yoon; James Theiler; Werner Abfalterer; Nick Hengartner; Elena E Giorgi; Tanmoy Bhattacharya; Brian Foley; Kathryn M Hastie; Matthew D Parker; David G Partridge; Cariad M Evans; Timothy M Freeman; Thushan I de Silva; Charlene McDanal; Lautaro G Perez; Haili Tang; Alex Moon-Walker; Sean P Whelan; Celia C LaBranche; Erica O Saphire; David C Montefiori
Journal:  Cell       Date:  2020-07-03       Impact factor: 66.850

10.  Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy.

Authors:  Hongjing Gu; Qi Chen; Guan Yang; Lei He; Hang Fan; Yong-Qiang Deng; Shibo Jiang; Shihui Sun; Cheng-Feng Qin; Yusen Zhou; Yanxiao Wang; Yue Teng; Zhongpeng Zhao; Yujun Cui; Yuchang Li; Xiao-Feng Li; Jiangfan Li; Na-Na Zhang; Xiaolan Yang; Shaolong Chen; Yan Guo; Guangyu Zhao; Xiliang Wang; De-Yan Luo; Hui Wang; Xiao Yang; Yan Li; Gencheng Han; Yuxian He; Xiaojun Zhou; Shusheng Geng; Xiaoli Sheng
Journal:  Science       Date:  2020-07-30       Impact factor: 47.728

View more
  30 in total

Review 1.  Structural and functional insights into the spike protein mutations of emerging SARS-CoV-2 variants.

Authors:  Deepali Gupta; Priyanka Sharma; Mandeep Singh; Mukesh Kumar; A S Ethayathulla; Punit Kaur
Journal:  Cell Mol Life Sci       Date:  2021-11-03       Impact factor: 9.261

Review 2.  Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences.

Authors:  Reem Hoteit; Hadi M Yassine
Journal:  Vaccines (Basel)       Date:  2022-06-09

3.  Identification of the SARS-CoV-2 Delta variant C22995A using a high-resolution melting curve RT-FRET-PCR.

Authors:  Subarna Barua; Jianfa Bai; Patrick John Kelly; Gregg Hanzlicek; Lance Noll; Calvin Johnson; Ji-Hang Yin; Chengming Wang
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163

Review 4.  D614G mutation and SARS-CoV-2: impact on S-protein structure, function, infectivity, and immunity.

Authors:  Manojit Bhattacharya; Srijan Chatterjee; Ashish Ranjan Sharma; Govindasamy Agoramoorthy; Chiranjib Chakraborty
Journal:  Appl Microbiol Biotechnol       Date:  2021-11-10       Impact factor: 4.813

5.  Studies on Growth Characteristics and Cross-Neutralization of Wild-Type and Delta SARS-CoV-2 From Hisar (India).

Authors:  Nitin Khandelwal; Yogesh Chander; Ram Kumar; Himanshu Nagori; Assim Verma; Priyasi Mittal; Riyesh T; Sameer Kamboj; Sukhbir Singh Verma; Subhash Khatreja; Yash Pal; Baldev R Gulati; Bhupendra N Tripathi; Sanjay Barua; Naveen Kumar
Journal:  Front Cell Infect Microbiol       Date:  2021-11-23       Impact factor: 5.293

6.  Potential therapeutic effect of glucagon-like peptide-1 receptor agonists on COVID-19-induced pulmonary arterial hypertension.

Authors:  Jong Han Lee
Journal:  Med Hypotheses       Date:  2021-12-09       Impact factor: 1.538

Review 7.  The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review.

Authors:  Sujay Paul; Luis Alberto Bravo Vázquez; Paula Roxana Reyes-Pérez; Carolina Estrada-Meza; Rafael Arturo Aponte Alburquerque; Surajit Pathak; Antara Banerjee; Anindya Bandyopadhyay; Samik Chakraborty; Aashish Srivastava
Journal:  Virus Res       Date:  2021-11-14       Impact factor: 3.303

8.  Intra-Host SARS-CoV-2 Evolution in the Gut of Mucosally-Infected Chlorocebus aethiops (African Green Monkeys).

Authors:  Lori A Rowe; Brandon J Beddingfield; Kelly Goff; Stephanie Z Killeen; Nicole R Chirichella; Alexandra Melton; Chad J Roy; Nicholas J Maness
Journal:  Viruses       Date:  2022-01-01       Impact factor: 5.048

9.  Emergence and Spread of a B.1.1.28-Derived P.6 Lineage with Q675H and Q677H Spike Mutations in Uruguay.

Authors:  Natalia Rego; Cecilia Salazar; Mercedes Paz; Alicia Costábile; Alvaro Fajardo; Ignacio Ferrés; Paula Perbolianachis; Tamara Fernández-Calero; Veronica Noya; Matias R Machado; Mariana Brandes; Rodrigo Arce; Mailen Arleo; Tania Possi; Natalia Reyes; María Noel Bentancor; Andrés Lizasoain; Viviana Bortagaray; Ana Moller; Odhille Chappos; Nicolas Nin; Javier Hurtado; Melissa Duquía; Maria Belén González; Luciana Griffero; Mauricio Méndez; Maria Pía Techera; Juan Zanetti; Emiliano Pereira; Bernardina Rivera; Matías Maidana; Martina Alonso; Pablo Smircich; Ighor Arantes; Daiana Mir; Cecilia Alonso; Julio Medina; Henry Albornoz; Rodney Colina; Gonzalo Bello; Pilar Moreno; Gonzalo Moratorio; Gregorio Iraola; Lucía Spangenberg
Journal:  Viruses       Date:  2021-09-10       Impact factor: 5.048

Review 10.  The Variation of SARS-CoV-2 and Advanced Research on Current Vaccines.

Authors:  Yao Jiang; Qian Wu; Peipei Song; Chongge You
Journal:  Front Med (Lausanne)       Date:  2022-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.